Zoryve (roflumilast)

$679.00

We can help with your prescription. Read the “Prescription Guide”.

You can access this medicine even if it’s not approved in your country. Learn how.

Price Frequently Asked Questions Details Patient stories Import guides

Zoryve (roflumilast) cream 0.3% is a topical PDE4 inhibitor indicated for the treatment of plaque psoriasis, including intertriginous areas, in patients 12 years of age or older. Zoryve was approved by the FDA in July 2022.

0.3% of roflumilast x 1 tube of 60 g

Clear

SKU: N/A Category: Dermatology

Buy Zoryve (roflumilast)

What is Zoryve (roflumilast) for?

Zoryve (roflumilast) is a phosphodiesterase 4 inhibitor indicated for topical treatment of plaque psoriasis, including intertriginous areas, in patients 12 years of age and older. Zoryve is indicated for topical use on the affected areas, once daily.

Where has Zoryve (roflumilast) been approved?

In July 2022, the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Zoryve (roflumilast) cream 0.3% for the treatment of plaque psoriasis, including intertriginous areas, in patients 12 years of age or older. Read more about it here.

The prescribing information for Zoryve (roflumilast) can be consulted here.